Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onbelay Capital is a private Canadian investment firm based in Cambridge, Ontario that provides equity capital and strategic assistance to early-stage, growth, and pre-public companies. The firm was founded in 1995 and is led by John K. Bell. Its portfolio spans multiple sectors, including selected life sciences and healthcare-related investments such as oncology, pulmonary therapeutics, drug delivery, cannabis, and medtech-adjacent businesses, but Onbelay itself is not a biotech or pharmaceutical developer. Rather than operating a therapeutic pipeline, it functions as an investor and strategic advisor to entrepreneurial companies. The firm appears to remain active and privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onbelay Capital.